Public case informationLast updated

Embecta Securities Class Action

Embecta · Common stock · Ongoing Litigation

About this case

A securities class action was filed on behalf of investors who purchased or otherwise acquired Embecta securities from November 25, 2025, through May 4, 2026. The complaint alleges that Embecta and its management knew or recklessly disregarded weakness in the U.S. pen needle market while reaffirming revenue guidance, before the company reported disappointing results and lowered its guidance. The matter is in ongoing litigation, and the lead-plaintiff deadline stated in the notice has passed.

Case overview

Defendant company
Embecta
Product or service
Common stock
Case name
Harrison Apitz-Grossman v. Embecta Corp., et al.
Court case number
2:26-cv-07217
Case status
Ongoing Litigation
Lawsuit type
Securities
Reported harm
Other

Important dates

Embecta Lead Plaintiff Application
Embecta Class Action Law Firm Intake

Participation information

Embecta Lead Plaintiff Application

Investors who purchased or otherwise acquired Embecta securities during the stated class period could seek appointment as lead plaintiff.

A proposed class member had to move the court no later than August 17, 2026, to serve as lead plaintiff. Seeking lead-plaintiff status was not required to potentially share in any recovery.

Type
Lead Plaintiff
Status
Deadline passed
Reported proof requirement
Unclear

Embecta Class Action Law Firm Intake

The law firm invited purchasers of Embecta common stock during the stated class period to contact it regarding the class action.

Use the law firm's intake page for information about contacting counsel.

Type
Law Firm Signup
Status
Deadline passed
Reported proof requirement
Unclear

Lead Plaintiff Application

The article states that shareholders who wish to serve as lead plaintiff should contact Robbins LLP. The proposed class consists of investors who purchased or otherwise acquired Embecta securities between November 25, 2025, and May 4, 2026.

Contact Robbins LLP for information about seeking appointment as lead plaintiff. The article states that shareholders may submit a form, email attorney Aaron Dumas, Jr., or call (800) 350-6003.

Type
Lead Plaintiff

Embecta Investor Case Evaluation

The article invites investors who purchased Embecta securities during the stated class period to contact Levi & Korsinsky for a case evaluation.

Contact Levi & Korsinsky using the contact information provided in the article.

Type
Law Firm Signup
Reported proof requirement
Unclear

Sources